Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103588833A reveals a novel tulathromycin synthesis avoiding toxic cyanide and expensive palladium, offering significant cost reduction and high purity for veterinary pharmaceutical manufacturing.
Patent CN101253144B details a novel Pd-catalyzed amination route for ortho-bicyclopropane anilines, offering cost reduction in fungicide manufacturing and enhanced supply chain reliability.
Patent CN1049435C details novel artemisinin derivatives with phenyl radicals. Discover cost-effective synthesis routes and supply chain advantages for API manufacturing.
Novel 3-step synthesis of FR20 inhibitor avoids toxic reagents. High atom economy and scalable process for pharmaceutical intermediates.
Patent CN105734089A reveals enzymatic synthesis for pharmaceutical intermediates. Offers high optical purity and scalable production for global supply chains.
Novel patent CN119350189A details safer synthesis of chiral peptide intermediates ensuring high purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN116496171A details a novel reductive amination route for Iohexol, eliminating genotoxic impurities and ensuring high-purity pharmaceutical intermediates supply.
Patent CN115160146B reveals a high-yield one-pot synthesis for 1,2-cyclohexanediamine from cyclohexene oxide, offering significant cost reduction and supply chain stability for global buyers.
Patent CN111362842B details a green aqueous method for para-selective amination. Offers cost-effective scaling for pharmaceutical intermediates.
Patent CN106518935A reveals a high-yield synthesis route for 3,6-dideoxy-3-amino-L-idose, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN113106078B reveals novel LaLeuDH mutants enabling 1.5M substrate tolerance and coenzyme-free synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111482178A details a continuous fixed-bed process for chloroquine intermediates using supported nano-nickel, offering high purity and reduced environmental impact for reliable supply chains.
Novel hydrogenation method for 2-clopentylamino ethanol ensures high purity and cost efficiency. Ideal for reliable fine chemical intermediate supplier partnerships.
Patent CN114507174A reveals a streamlined synthesis for Amisulpride Impurity H. Discover high-purity production methods and cost-effective supply chain solutions.
Novel catalytic route for Duvelisib intermediates ensures high purity and scalable production for global pharmaceutical supply chains and cost efficiency.
Patent CN112939993B9 reveals novel benzopyran derivatives enhancing OLED efficiency and lifespan. Discover scalable synthesis routes and supply chain advantages for electronic chemical manufacturing.
Patent CN112194558B details a robust 3-step synthesis for a key pharmaceutical intermediate, offering high purity, scalable yields, and cost-effective manufacturing solutions.
Novel reductive amination route for Rivastigmine intermediate CN101016257A. Enhances yield and purity for API manufacturing supply chains.
Novel patent CN105061245A details moderate conditions for Safinamide. Offers supply chain reliability and cost reduction in API manufacturing.
Patent CN110054656B details a novel oxidation method for synthesizing M6G impurities, offering reliable supply chain solutions for pharmaceutical quality control and regulatory compliance.